Ratings
Positive
Theravance anticipates $150M in milestones as CYPRESS trial nears pivotal data readout
Breaking news from global financial markets
2 months ago
Read More
2 months ago
4,291
2 months ago
4,696
2 months ago
3,625
2 months ago
707
2 months ago
3,592
2 months ago
916
2 months ago
4,256
2 months ago
1,374
2 months ago
3,370
2 months ago
738
2 months ago
3,529
2 months ago
2,715
2 months ago
3,966
2 months ago
3,975
2 months ago
1,692
Trending Now
1
Ethereum Price Reclaims $3,600 as BitMine Buys Another 18,271 ETH
2,129
12 minutes ago
2
ATYR Investor Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class...
31,519
16 minutes ago
3
James Hardie Industries (JHX) Lawsuit Alleges Securities Fraud Over Inventory Mi...
19,974
19 minutes ago
4
Lamarina, The Cove & Cucina: 5th Palm Beach CorpGov Forum Social Events
46,520
19 minutes ago
5
Intellia Therapeutics Presents Positive Longer-Term Phase 1 Data of Nexiguran Zi...
4,486
22 minutes ago